期刊文献+

乳腺癌术后辅助治疗疗效分析 被引量:2

An Analysis of Effect Postoperative Adjuvant Therapy for Breast Cancer
下载PDF
导出
摘要 目的 探索乳腺癌根治术后患者病期、淋巴结情况及治疗方法对生存率的影响。方法对比分析我科收治的乳腺癌术后Ⅱ期 110例和Ⅲ期 90例 ,采用术后放疗、术后化疗及术后放疗加化疗进行治疗。结果 Ⅱ期和Ⅲ期乳腺癌患者术后放疗、术后化疗 +放疗局部复发率均低于术后化疗 (P <0 0 5) ;Ⅲ期患者远处转移率术后放疗高于术后化疗或术后放疗 +化疗 (P <0 0 5) ;Ⅱ期乳腺癌腋窝淋巴结转移数≥ 4个 ,生存率下降 ;Ⅲ期乳腺癌患者随着N的升级 ,五年生存率逐渐降低。结论 乳腺癌术后放疗可以减少局部复发率 ;Ⅲ期乳腺癌术后化疗可降低远处转移率 ;淋巴结转移数影响 5年生存率。 To study the effect of stage, Iymph nodes and therapy methods on the survival rate for breast cancer after radical operation.Methods Treatment results were compared between 110 stage Ⅱ and 90 stage Ⅲ breast cancers who received postoperative radiotherapy(RT),Chemotherapy (CT)and chemotherapy plus radiotherapy (CRT) in our department.Results The local recurrence rates for stage Ⅱ and stage Ⅲ with RT group and CRT group compared with CT group have significance ( P <0 05).Distance metastasis rates for stage Ⅲ patients with CT group and CRT group compared with CT group have significance ( P <0 05).The 5-year survival rates for patients with ≥4 positive axillarys Iymph nodes in stage Ⅱ decrease ( P <0 05),The 5-year survival rates of stage Ⅲ breast cancer declined gradually with increase of the N.Conclusion Postoperative RT of breast cancer could reduce the local recurrence rates.Postoperative CT for stage Ⅲ breast cancer could reduce distance metastasis rates.Axillarys Iymph nodes effect on the 5-year survival rates.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2000年第5期398-399,401,共3页 Cancer Research on Prevention and Treatment
关键词 乳腺癌 外科手术 术后 辅助治疗 疗效 stage Ⅱ and Ⅲ breast cancer treatment analysis
  • 相关文献

参考文献7

二级参考文献11

共引文献53

同被引文献14

  • 1惠周光,余子豪.我国乳腺癌改良根治术后放疗现状的调查分析[J].中华放射肿瘤学杂志,2005,14(6):471-475. 被引量:41
  • 2李树羚.乳腺肿瘤学[M].北京:科学技术文献出版社,2000.436-437.
  • 3Fisher b, Anderson S, Wickerham L, et al. Increased intensification and total dose of breast cancer, findings from the National Surgical Adjuvant Breast and Bowel Project B-22[J]. J Clin Oncol, 1997,15(5) : 1858-1869.
  • 4Bonadonna G, Zambetti M, Valagussa P. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes[J]. J AMA, 1995,273 (7) : 542- 547.
  • 5Bonadonna G, Valagussa P, Brambilla C, et al,Primary chem. otherapy in operable breast cancer, eight-year experience at the Milan cancer Institute [J]. J Clin oncol, 1998,16(1 ):93-100.
  • 6Early Breast Cancer Trialists'Collaborative Group. Polychemotherapy for early breast cancer, an overview of the randomised trails [J]. Lancet, 1998,352(9132):930-942.
  • 7Fowble B, Resuits of prospective randomised trials evaluating postmasteetomy radioation for axillary node-positive patients receiving adjuvant systemic therapy[M]. American society of Clinical Oncology Educational Book 35 the Annual Meeting. Atlanta: spring, 1999:623- 628.
  • 8Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and surger in early breast cancer , An overview of the randomized tria[J]. N Engl J Med, 1995, 333(22): 1444-1145.
  • 9余子豪.乳腺癌[M].殷蔚伯主编.肿瘸放射治疗学[C].北京:中国协和医科大学出版社,2002.1078.
  • 10申文江.关于乳腺癌治疗的趋势[J].中国放射肿瘤学,1988,2:58-58.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部